Insulin aspart, recombinant Subcutaneous and Lisdexamfetamine Capsules
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Lisdexamfetamine Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: lisdexamfetamine
Brand name: Vyvanse
Synonyms: Lisdexamfetamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Lisdexamfetamine Chewable Tablets
- Insulin aspart, recombinant Subcutaneous-Lisdexamfetamine dimesylate
- Insulin aspart, recombinant Subcutaneous-Lisinopril
- Insulin aspart, recombinant Subcutaneous-Lisinopril and Hydrochlorothiazide
- Insulin aspart, recombinant Subcutaneous-Lisinopril Oral Solution
- Insulin aspart, recombinant Subcutaneous-Lisinopril Tablets
- Lisdexamfetamine Capsules-Insulin degludec
- Lisdexamfetamine Capsules-Insulin Degludec (U-100) Prefilled Pens
- Lisdexamfetamine Capsules-Insulin Degludec (U-100) Vials
- Lisdexamfetamine Capsules-Insulin Degludec (U-200) Prefilled Pens
- Lisdexamfetamine Capsules-Insulin degludec and liraglutide
- Lisdexamfetamine Capsules-Insulin degludec and liraglutide Subcutaneous